Table of Contents Table of Contents
Previous Page  19 / 23 Next Page
Information
Show Menu
Previous Page 19 / 23 Next Page
Page Background

Avelumab: ORR by subgroups, Part A, 2L

Kaufman HL, et al. Lancet Oncol. 2016;17(10):1374-85; Kaufman. AACR 2017